TRADEKA AND COLOSSEUM TO ACQUIRE MED GROUP
(21.02.2018)

Avance advises Tradeka-Yhtiöt Oy and Colosseum Dental Group in the acquisition of Med Group from Adelis Equity Partners and other shareholders. Med Group is a leading Finnish company concentrated on homecare, ambulance services, public healthcare staffing and private dental healthcare services.

The transaction is subject to customary regulatory approvals.

The Avance team included Ulf-Henrik Kull, Erkki-Antti Sadinmaa, Mikko Alkio, Rasmus Sundström, Katja Jaakkola, Linda Nguyen, Elina Saviharju, Victor Fagerlund, Malin Holm, Eeva Riivari and Eino Rautanen.

EQT Ventures leads USD 41 million investment in Small Giant Games
(21.02.2018)

Small Giant Games concludes a $41 million investment round, whereby the company secures new financing to increase its reach internationally, expand its team and continue innovation on its Empires & Puzzles game and upcoming titles. A significant share of the investment was also used to acquire shares from the founders and employees. The round was led by EQT Ventures, along with other existing investors Creandum, Spintop Ventures, and PROfounders.

Launched globally on Android and iOS in March 2017, Empires & Puzzles is an original IP match-3 role playing game (RPG). Built in less than a year with a team of just 12 developers, Empires & Puzzles is now one of the few new entrants in recent years to successfully break into the top 100 grossing gaming apps in key western markets. To date, the game has secured 10 million players worldwide and has a very active user base with a DAU/MAU ratio of 33 percent. Small Giant Games also reports $33 million of revenue for Empires & Puzzles in 2017 - just 10 months after its launch.

The Avance team included Ilkka Perheentupa and Anders Floman.

NCC divests retail projects to Niam
(02.02.2018)

Avance advises NCC Property Development in the divestment of two retail projects to a fund managed by Niam. The Suurpelto shopping centre In Espoo opened in November 2017 and the Laajasalo shopping centre in Helsinki is under construction and planned to open in November 2018. The combined transaction value is approx. EUR 54 million.

The Avance team included Mathias Lindqvist, Henrikki Tahkokallio and Eino Rautanen.

SALE OF MAJORITY STAKE IN MEDIX BIOCHEMICA
(01.02.2018)

Avance advises Minerva Foundation, Folkhälsans forskningsstiftelse and Medicinska Understödsföreningen Liv och Hälsa in the sale of a majority stake in Finnish biotechnology company Medix Biochemica to DevCo Partners. Following the transaction, Minerva Foundation will continue as a significant shareholder in the company. Medix Biochemica is a leading manufacturer of bioreagents for the global IVD industry. In addition, it offers diagnostic tests specifically designed for the women’s health sector.
 
The Avance team included Ulf-Henrik Kull, Robin Nordblad and Anders Floman.